跳至主要内容
临床试验/NCT04234659
NCT04234659
已完成
不适用

Observational Study for Outcomes for Participants With Cardiogenic Shock and Peripartum Cardiomyopathy

Medical College of Wisconsin1 个研究点 分布在 1 个国家目标入组 150 人2021年1月11日

概览

阶段
不适用
干预措施
Clinical placement of a temporary IMPELLA® mechanical circulatory support device.
疾病 / 适应症
Peripartum Cardiomyopathy
发起方
Medical College of Wisconsin
入组人数
150
试验地点
1
主要终点
Description of the Long-term Clinical Course of Patients with Peripartum Cardiomyopathy complicated by cardiogenic shock.
状态
已完成
最后更新
2个月前

概览

简要总结

The purpose of this study is to examine the clinical treatment of patients diagnosed with peripartum cardiomyopathy complicated by cardiogenic shock.

详细描述

This single-site, virtual, longitudinal, observational study will investigate two cohorts (study groups) by enrolling a total of ten participants, five in each cohort. The two cohorts include individuals who received mechanical circulatory support (specifically the IMPELLA® device) compared to individuals who did not receive mechanical circulatory support for treatment of their PPCM complicated by cardiogenic shock index event. The duration of enrollment for each participant is about 5 months. It is anticipated that the trial will be complete in 12 months. Participant engagement to the study will be self-initiated. Under the guidance and support of Medical College of Wisconsin research coordinator, participants will directly access the study REDCapTM database for enrollment and follow-up data entry for this study. The research coordinator will obtain and abstract participant medical records documenting the event.

注册库
clinicaltrials.gov
开始日期
2021年1月11日
结束日期
2025年8月5日
最后更新
2个月前
研究类型
Observational
性别
Female

研究者

责任方
Sponsor
主要研究者

Sarah Thordsen

Assistant Professor Cardiovascular Medicine

Medical College of Wisconsin

入排标准

入选标准

  • age ≥ 18 years old at the time of entry into the study
  • who have capacity to provide consent for study participation
  • with self-reported PPCM complicated by cardiogenic shock
  • individuals should have US citizenship
  • index event occurring within the continental United States.

排除标准

  • lack of medical records supporting pregnancy, peripartum cardiomyopathy or cardiogenic shock by study definition
  • inability of participant to provide informed consent

研究组 & 干预措施

Individuals Receiving Mechanical Circulatory Device Support

Individuals receiving mechanical circulatory support device (specifically the IMPELLA® device) for treatment of their index peripartum cardiomyopathy complicated by cardiogenic shock event.

干预措施: Clinical placement of a temporary IMPELLA® mechanical circulatory support device.

Individuals Without Mechanical Circulatory Device Support

Individuals not receiving mechanical circulatory support device (specifically the IMPELLA® device) for treatment of their index peripartum cardiomyopathy complicated by cardiogenic shock event.

结局指标

主要结局

Description of the Long-term Clinical Course of Patients with Peripartum Cardiomyopathy complicated by cardiogenic shock.

时间窗: From onset of event through 90 days after participant enrollment.

The retrospective and prospective data collected from study participants will report clinical treatments required to treat the diagnosis of peripartum cardiomyopathy complicated by cardiogenic shock.

研究点 (1)

Loading locations...

相似试验